Lithium treatment over the lifespan in bipolar disorders
C Volkmann, T Bschor, S Köhler - Frontiers in Psychiatry, 2020 - frontiersin.org
Lithium has been the treatment of choice for patients with bipolar disorder (BD) for nearly 70
years. It is recommended by all relevant guidelines as a first-line treatment for maintenance …
years. It is recommended by all relevant guidelines as a first-line treatment for maintenance …
[HTML][HTML] Acute and long term treatment of manic episodes in bipolar disorder
Bipolar disorder is a disabling psychiatric disorder which causes premature death and loss
of quality of life. Despite the developments, novel treatments are partially effective and …
of quality of life. Despite the developments, novel treatments are partially effective and …
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder
M Poyurovsky, L Braverman… - International Clinical …, 2021 - journals.lww.com
Obsessive-compulsive disorder (OCD) is a prevalent and clinically significant comorbid
condition in patients with bipolar disorder. Treatment of bipolar disorder/OCD patients is …
condition in patients with bipolar disorder. Treatment of bipolar disorder/OCD patients is …
Risperidone-induced fecal incontinence: a case report
B Aygun, A Karayagmurlu… - … ADAM-JOURNAL OF …, 2022 - avesis.istanbul.edu.tr
Fecal incontinence is defined as the inability to postpone or control the defecation
requirement until socially convenient. There are many effective factors in its etiology. Drugs …
requirement until socially convenient. There are many effective factors in its etiology. Drugs …
[PDF][PDF] Bipolar Bozukluk-Manik Dönemin Akut ve İdame Tedavisi.
Bipolar bozukluk erken ölüm ve engelliliğe sebep olabilen psikiyatrik bir bozukluktur. Yeni
gelişmelere rağmen, tedavide kısmen başarı sağlanabilmekte ve yanıt yetersiz kaldığında …
gelişmelere rağmen, tedavide kısmen başarı sağlanabilmekte ve yanıt yetersiz kaldığında …
Medications for Bipolar Disorder
PB Mitchell - Tasman's Psychiatry, 2024 - Springer
This chapter reviews current evidence for medications in the treatment of patients with
bipolar disorder. It will overview the historic “mood stabilizers” such as lithium, valproate …
bipolar disorder. It will overview the historic “mood stabilizers” such as lithium, valproate …
[HTML][HTML] Primary outcomes, secondary outcomes, and their relevance to how many papers are published from a study: A primer for authors, reviewers, and editors
V Menon, SK Praharaj, C Andrade - Indian Journal of Psychiatry, 2024 - journals.lww.com
In research, outcomes are often categorized as primary and secondary. The primary
outcome is the most important one; it determines whether the study is considered …
outcome is the most important one; it determines whether the study is considered …
Current situation and influencing factors of acute treatment of bipolar disorder with mixed features in China
B Fu, L Tang, S Zhang, Y Zhu, Z Chen, G Xu… - Authorea …, 2024 - essopenarchive.org
Background: DSM-5 proposes the concept of bipolar disorder with “mixed features”, which is
of great benefit to clinical practice. However, the clinical management of BD with mixed …
of great benefit to clinical practice. However, the clinical management of BD with mixed …
Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients
B Uyar, A Atlı, DG Bilen - Cukurova Medical Journal, 2022 - dergipark.org.tr
Purpose: This study aims to determine the usage frequency of long-acting injectable
antipsychotics among bipolar disorder type 1 patients who presented to the Dicle University …
antipsychotics among bipolar disorder type 1 patients who presented to the Dicle University …
Arypiprazol–teoria i praktyka
A Szulc - Medycyna Faktów, 2022 - journalsmededu.pl
Arypiprazol jest jednym z leków przeciwpsychotycznych II generacji, inaczej–atypowych,
znanym od kilkunastu lat. Ma unikalny profil receptorowy względem pozostałych leków …
znanym od kilkunastu lat. Ma unikalny profil receptorowy względem pozostałych leków …